Skip to main content
. 2021 Dec 9;21:426. doi: 10.1186/s12886-021-02196-8

Table 3.

Incidence rate and hazard ratio of PD between with and without age-related macular degeneration stratified by sex, age, comorbidity, numbers of comorbidity, and medication

Variable Age-related Macular Degeneration Crude HR (95% CI) Adjusted HR (95% CI)
No Yes
Event PY IR Event PY IR
Sex
 Female 115 28,927 3.98 191 29,623 6.45 1.62 (1.29–2.04)*** 1.42 (1.13–1.80)**
 Male 160 28,240 5.67 242 29,385 8.24 1.45 (1.19–1.78)*** 1.28 (1.05–1.57)*
Age, years
 50–59 9 10,684 0.84 18 10,445 1.72 2.05 (0.92–4.56) 1.31 (0.57–3.01)
 60–69 60 18,836 3.19 100 18,814 5.32 1.67 (1.21–2.30)** 1.51 (1.09–2.09)*
 70–79 148 20,681 7.16 216 22,159 9.75 1.36 (1.10–1.68)** 1.30 (1.05–1.60)*
 80–100 58 6967 8.32 99 7589 13.0 1.57 (1.14–2.17)** 1.40 (1.01–1.95)*
Comorbidity
 Osteoporosis 51 9755 5.23 131 13,631 9.61 1.82 (1.32–2.52)*** 1.68 (1.22–2.33)**
 Diabetes 109 18,056 6.04 222 26,020 8.53 1.41 (1.12–1.78)** 1.41 (1.12–1.78)**
 Cirrhosis 94 15,195 6.19 169 22,003 7.68 1.25 (0.97–1.60) 1.20 (0.93–1.54)
 Cerebrovascular disease 92 9742 9.44 159 13,324 11.93 1.27 (0.98–1.64) 1.25 (0.96–1.62)
 Chronic kidney disease 18 1942 9.27 27 2904 9.30 1.02 (0.56–1.85) 0.99 (0.54–1.81)
 Hypertension 206 33,161 6.21 357 40,520 8.81 1.41 (1.19–1.68)*** 1.36 (1.15–1.62)***
 Hyperlipidemia 86 15,963 5.39 156 22,973 6.79 1.27 (0.97–1.65) 1.17 (0.90–1.52)
 Coronary artery disease 23 2596 8.86 36 3965 9.08 1.02 (0.60–1.71) 1.01 (0.59–1.70)
 Chronic obstructive pulmonary disease 117 16,690 7.01 192 22,017 8.72 1.25 (0.99–1.57) 1.19 (0.94–1.50)
Numbers of comorbidity
 0 28 12,790 2.19 13 6184 2.10 0.95 (0.49–1.84) 0.95 (0.49–1.85)
  ≥ 1 247 44,378 5.57 420 52,823 7.95 1.43 (1.22–1.67)* 1.40 (1.20–1.64)***
Medication
 Statin 208 44,636 4.66 332 44,596 7.44 1.60 (1.34–1.90)*** 1.42 (1.19–1.69)***
 CCB 207 42,835 4.83 329 44,916 7.32 1.52 (1.27–1.80)*** 1.32 (1.11–1.58)**

Abbreviations: aHR Adjusted Hazard Ratio estimated by the model including the variables of age-related macular degeneration, sex, age, osteoporosis, diabetes, cirrhosis, cerebrovascular disease, chronic kidney disease, hypertension, hyperlipidemia, coronary artery disease, chronic obstructive pulmonary disease, statin, and CCB, CCB Calcium Channel Blocker, CI Confidence Interval, HR Hazard Ratio, IR Incidence Rate, per 1000 person-years, PY Person-Years

*p < 0.05; **p < 0.01; ***p < 0.001